Inhibiting the platelet derived growth factor receptor increases signs of retinoic acid syndrome in myeloid differentiated HL-60 cells

FEBS Letters

Volumn 582, Issue 17, 2008, Pages 2508-2514

  Reiterer, Gudrun ^a   Bunaciu, Rodica P ^a   Smith, James L ^a   Yen, Andrew ^a  

^a Cornell University ^*  (United States)

Author keywords

Cytokine; Endothelial cell; Integrin; Leukemia; MMP 9; RAS

Indexed keywords

6,7 DIMETHOXY 2 PHENYLQUINOXALINE; CD18 ANTIGEN; GELATINASE B; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

AEROBIC METABOLISM; ARTICLE; CELL INTERACTION; CELL MOTILITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RETINOIC ACID SYNDROME;

ANTIGENS, CD18; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIFFERENTIATION; CELL MOVEMENT; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL CELLS; HL-60 CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIGANDS; MACROPHAGE-1 ANTIGEN; MATRIX METALLOPROTEINASE 9; PROTEIN KINASE INHIBITORS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SYNDROME; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA; TYRPHOSTINS;

EID: 46949106575     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.06.016     Document Type: Article

References (25)

1. Wang Z.Y., and Chen Z. Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia. Lancet Oncol. 1 (2000) 101-106
2. Tallman M.S. Differentiating therapy with all-trans retinoic acid in acute myeloid leukemia. Leukemia 10 Suppl. 1 (1996) S12-S15
3. Fenaux P., Wang Z.Z., and Degos L. Treatment of acute promyelocytic leukemia by retinoids. Curr. Top. Microbiol. Immunol. 313 (2007) 101-128
4. Hsu H.C., Tsai W.H., Chen P.G., Hsu M.L., Ho C.K., and Wang S.Y. In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells. Eur. J. Haematol. 63 (1999) 11-18
5. Hordijk P.L. Endothelial signalling events during leukocyte transmigration. FEBS J. 273 (2006) 4408-4415
6. Cox B.D., Natarajan M., Stettner M.R., and Gladson C.L. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J. Cell Biochem. 99 (2006) 35-52
7. Yen A., Forbes M., DeGala G., and Fishbaugh J. Control of HL-60 cell differentiation lineage specificity, a late event occurring after precommitment. Cancer Res. 47 (1987) 129-134
8. Yen A., Brown D., and Fishbaugh J. Control of HL-60 monocytic differentiation. Different pathways and uncoupled expression of differentiation markers. Exp. Cell Res. 168 (1987) 247-254
9. Levitzki A. PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases. Cytokine Growth Factor Rev. 15 (2004) 229-235
10. Reiterer G., and Yen A. Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cells. Cancer Res. 67 (2007) 7765-7767
11. Bjorklund M., Aitio O., Stefanidakis M., Suojanen J., Salo T., Sorsa T., and Koivunen E. Stabilization of the activated alphaMbeta2 integrin by a small molecule inhibits leukocyte migration and recruitment. Biochemistry 45 (2006) 2862-2871
12. Baron V., and Schwartz M. Cell adhesion regulates ubiquitin-mediated degradation of the platelet-derived growth factor receptor beta. J. Biol. Chem. 275 (2000) 39318-39323
13. Zaslavsky A., Li S., and Xu Y. Sphingosine-1-phosphate induces a PDGFR-dependent cell detachment via inhibiting beta1 integrin in HEK293 cells. FEBS Lett. 579 (2005) 3899-3906
14. Faccio R., Novack D.V., Zallone A., Ross F.P., and Teitelbaum S.L. Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin. J. Cell Biol. 162 (2003) 499-509
15. Lygoe K.A., Wall I., Stephens P., and Lewis M.P. Role of vitronectin and fibronectin receptors in oral mucosal and dermal myofibroblast differentiation. Biol. Cell 99 (2007) 601-614
16. Woods A., Wang G., and Beier F. Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions. J. Cell Physiol. 213 (2007) 1-8
17. Sudhakaran P.R., Radhika A., and Jacob S.S. Monocyte macrophage differentiation in vitro: fibronectin-dependent upregulation of certain macrophage-specific activities. Glycoconj. J. 24 (2007) 49-55
18. Komano Y., Nanki T., Hayashida K., Taniguchi K., and Miyasaka N. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res. Ther. 8 (2006) R152
19. Ma Y.Q., Plow E.F., and Geng J.G. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. Blood 104 (2004) 2549-2556
20. Verma R.P., and Hansch C. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg. Med. Chem. 15 (2007) 2223-2268
21. Cools J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. New Engl. J. Med. 348 (2003) 1201-1214
22. Golub T.R., Barker G.F., Lovett M., and Gilliland D.G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77 (1994) 307-316
23. Magnusson M.K., Meade K.E., Brown K.E., Arthur D.C., Krueger L.A., Barrett A.J., and Dunbar C.E. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia. Blood 98 (2001) 2518-2525
24. Ostman A., and Heldin C.H. Involvement of platelet-derived growth factor in disease: development of specific antagonists. Adv. Cancer Res. 80 (2001) 1-38
25. Pietras K., Sjoblom T., Rubin K., Heldin C.H., and Ostman A. PDGF receptors as cancer drug targets. Cancer Cell 3 (2003) 439-443